In the past decade, we’ve made significant strides in the treatment of breast cancer. We’ve refined strategies to treat both hormone-positive and hormone-negative disease, developed targeted treatments for patients with specific tumor subtypes, and advanced our approaches to early-stage and metastatic breast cancer.
Still, breast cancer is the most common cancer among women in the United States, accounting for nearly 1 of every 3 cancers diagnosed, and is the cause of significant morbidity and mortality.
Additionally, changing (and sometimes conflicting) clinical guidelines related to breast cancer screening continue to generate controversy in both the medical literature and the lay media.
The result? Perplexed patients and their clinicians are navigating decisions about potentially life-changing diagnostics and treatments in real-time in the midst of ongoing debate about the value and limitations of screening and risk assessment for individual patients.
Because physicians are challenged to stay up to date on advances in screening, assessment and management of women with breast cancer, the Massachusetts Medical Society is proud to announce a new continuing medical education program, Breast Cancer Seminar Series: Personalized Treatment in Breast Cancer: Improving Outcomes in Advanced Disease .
Sponsored by MMS and chaired by Karen Antman, MD, Dean of the Boston University School of Medicine, this live virtual CME summit brings together leading experts in breast cancer research and clinical practice — live and online — to discuss the latest topics and new developments in breast cancer.
Watch Eric Winer, MD, of the Dana Farber Cancer Center present his perspectives on optimizing treatment for patients with triple negative disease, for example, and compare your decision-making in managing patients with locally advanced and metastatic cancers to that of faculty member William Gradishar, MD, of the Northwestern Feinberg School of Medicine.
Attend our free, online interactive program from on Monday, June 18, and earn up to 4.0 AMA Category 1 Credits(TM). The Virtual Education Breast Cancer Seminar Series will be conducted live and online from 11am until 3pm ET, and tuition is complimentary. View the full agenda and speakers, and sign up now at the Clinical Series Live.